These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
565 related articles for article (PubMed ID: 18974782)
41. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression. Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945 [TBL] [Abstract][Full Text] [Related]
42. Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue of HIV-1-infected subjects. Shacklett BL; Beadle TJ; Pacheco PA; Grendell JH; Haslett PA; King AS; Ogg GS; Basuk PM; Nixon DF Virology; 2000 May; 270(2):317-27. PubMed ID: 10792991 [TBL] [Abstract][Full Text] [Related]
43. Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy. Khoury G; Fromentin R; Solomon A; Hartogensis W; Killian M; Hoh R; Somsouk M; Hunt PW; Girling V; Sinclair E; Bacchetti P; Anderson JL; Hecht FM; Deeks SG; Cameron PU; Chomont N; Lewin SR J Infect Dis; 2017 Mar; 215(6):911-919. PubMed ID: 28453847 [TBL] [Abstract][Full Text] [Related]
44. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection. Oxenius A; Price DA; Günthard HF; Dawson SJ; Fagard C; Perrin L; Fischer M; Weber R; Plana M; García F; Hirschel B; McLean A; Phillips RE Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13747-52. PubMed ID: 12370434 [TBL] [Abstract][Full Text] [Related]
45. Plasmacytoid dendritic cell and functional HIV Gag p55-specific T cells before treatment interruption can inform set-point plasma HIV viral load after treatment interruption in chronically suppressed HIV-1(+) patients. Papasavvas E; Foulkes A; Yin X; Joseph J; Ross B; Azzoni L; Kostman JR; Mounzer K; Shull J; Montaner LJ Immunology; 2015 Jul; 145(3):380-90. PubMed ID: 25684333 [TBL] [Abstract][Full Text] [Related]
46. Deficiency of HIV-Gag-specific T cells in early childhood correlates with poor viral containment. Huang S; Dunkley-Thompson J; Tang Y; Macklin EA; Steel-Duncan J; Singh-Minott I; Ryland EG; Smikle M; Walker BD; Christie CD; Feeney ME J Immunol; 2008 Dec; 181(11):8103-11. PubMed ID: 19018003 [TBL] [Abstract][Full Text] [Related]
47. Changes in levels of T cell subpopulations to monitor the response to antiretroviral therapy among HIV-1-infected patients during two years of HIV-1 replication suppression. Zhang JC; Zhang HJ; Li Y; Jing D; Liu Q; Zhao K; Liu QQ; Zhuang Y; Kang WZ; Sun YT Scand J Infect Dis; 2013 May; 45(5):368-77. PubMed ID: 23186319 [TBL] [Abstract][Full Text] [Related]
48. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy. Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390 [TBL] [Abstract][Full Text] [Related]
49. A high viral burden predicts the loss of CD8 T-cell responses specific for subdominant gag epitopes during chronic human immunodeficiency virus infection. Geldmacher C; Gray C; Nason M; Currier JR; Haule A; Njovu L; Geis S; Hoffmann O; Maboko L; Meyerhans A; Cox J; Hoelscher M J Virol; 2007 Dec; 81(24):13809-15. PubMed ID: 17898052 [TBL] [Abstract][Full Text] [Related]
50. Trafficking of human immunodeficiency virus type 1-specific CD8+ T cells to gut-associated lymphoid tissue during chronic infection. Shacklett BL; Cox CA; Sandberg JK; Stollman NH; Jacobson MA; Nixon DF J Virol; 2003 May; 77(10):5621-31. PubMed ID: 12719554 [TBL] [Abstract][Full Text] [Related]
51. Predicting the impact of CD8+ T cell polyfunctionality on HIV disease progression. Graw F; Regoes RR J Virol; 2014 Sep; 88(17):10134-45. PubMed ID: 24965450 [TBL] [Abstract][Full Text] [Related]
52. Correlation between gag-specific CD8 T-cell responses, viral load, and CD4 count in HIV-1 infection is dependent on disease status. Jiao Y; Xie J; Li T; Han Y; Qiu Z; Zuo L; Wang A J Acquir Immune Defic Syndr; 2006 Jul; 42(3):263-8. PubMed ID: 16763520 [TBL] [Abstract][Full Text] [Related]
53. Profile of immunologic recovery in HIV-infected Ugandan adults after antiretroviral therapy. Baker CA; Emenyonu N; Ssewanyana I; Jones NG; Elrefaei M; Nghania F; Nakiwala J; Andia I; Clark R; Martin J; Bangsberg DR; Cao H AIDS Res Hum Retroviruses; 2007 Jul; 23(7):900-5. PubMed ID: 17678474 [TBL] [Abstract][Full Text] [Related]
54. Parallel human immunodeficiency virus type 1-specific CD8+ T-lymphocyte responses in blood and mucosa during chronic infection. Ibarrondo FJ; Anton PA; Fuerst M; Ng HL; Wong JT; Matud J; Elliott J; Shih R; Hausner MA; Price C; Hultin LE; Hultin PM; Jamieson BD; Yang OO J Virol; 2005 Apr; 79(7):4289-97. PubMed ID: 15767429 [TBL] [Abstract][Full Text] [Related]
55. Emergence of a distinct HIV-specific IL-10-producing CD8+ T-cell subset with immunomodulatory functions during chronic HIV-1 infection. Clutton G; Yang H; Hancock G; Sande N; Holloway C; Angus B; von Delft A; Barnes E; Borrow P; Pellegrino P; Williams I; McMichael A; Dorrell L Eur J Immunol; 2013 Nov; 43(11):2875-85. PubMed ID: 23897063 [TBL] [Abstract][Full Text] [Related]
56. Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts. Cao W; Mehraj V; Trottier B; Baril JG; Leblanc R; Lebouche B; Cox J; Tremblay C; Lu W; Singer J; Li T; Routy JP; ; Vézina S; Charest L; Milne M; Huchet E; Lavoie S; Friedman J; Duchastel M; Villielm F; Côté P; Potter M; Lessard B; Charron MA; Dufresne S; Turgeon ME; Rouleau D; Labrecque L; Fortin C; de Pokomandy A; Hal-Gagné V; Munoz M; Deligne B; Martel-Laferrière V; Gilmore N; Fletcher M; Szabo J Clin Infect Dis; 2016 Jan; 62(2):250-257. PubMed ID: 26349551 [TBL] [Abstract][Full Text] [Related]
57. Distinct kinetics of Gag-specific CD4+ and CD8+ T cell responses during acute HIV-1 infection. Riou C; Ganusov VV; Campion S; Mlotshwa M; Liu MK; Whale VE; Goonetilleke N; Borrow P; Ferrari G; Betts MR; Haynes BF; McMichael AJ; Gray CM J Immunol; 2012 Mar; 188(5):2198-206. PubMed ID: 22287716 [TBL] [Abstract][Full Text] [Related]
58. Combination Immune Checkpoint Blockade Enhances IL-2 and CD107a Production from HIV-Specific T Cells Ex Vivo in People Living with HIV on Antiretroviral Therapy. Chiu CY; Chang JJ; Dantanarayana AI; Solomon A; Evans VA; Pascoe R; Gubser C; Trautman L; Fromentin R; Chomont N; McMahon JH; Cameron PU; Rasmussen TA; Lewin SR J Immunol; 2022 Jan; 208(1):54-62. PubMed ID: 34853078 [TBL] [Abstract][Full Text] [Related]
59. Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point. Northfield JW; Loo CP; Barbour JD; Spotts G; Hecht FM; Klenerman P; Nixon DF; Michaëlsson J J Virol; 2007 Jun; 81(11):5759-65. PubMed ID: 17376902 [TBL] [Abstract][Full Text] [Related]
60. Impact of human immunodeficiency virus 1 infection and inflammation on the composition and yield of cervical mononuclear cells in the female genital tract. Nkwanyana NN; Gumbi PP; Roberts L; Denny L; Hanekom W; Soares A; Allan B; Williamson AL; Coetzee D; Olivier AJ; Burgers WA; Passmore JA Immunology; 2009 Sep; 128(1 Suppl):e746-57. PubMed ID: 19740336 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]